Your Search Results

Challenges of multivessel disease in ACS

21 May 2026 – From EuroPCR 2026

Dedicated to the challenges of multivessel disease in acute coronary syndrome (ACS), this session explores strategies to identify culprit versus non-culprit lesions and plan multivessel revascularisation using physiology, intravascular imaging, and artificial intelligence. It further discusses the timing considerations for revascularisation, whether ad-hoc or staged, illustrated...

Choosing the right tool to treat calcified bifurcation

19 May 2026 – From EuroPCR 2026

This session provides expert guidance on managing calcified bifurcation lesions. It highlights identification of high-risk scenarios, the role of coronary CT angiography and intravascular imaging in tool selection, and specialized techniques for treating calcified nodules in the left main coronary artery.

DCB: what we know and what we do not know

22 May 2026 – From EuroPCR 2026

This session provides a detailed update on drug-coated balloons (DCB) in interventional cardiology, covering the latest clinical data and trials. It identifies scenarios where DCB use is most effective and offers guidance on optimizing procedural techniques to enhance clinical outcomes.

All you need to know about interventional therapies for pulmonary embolism

20 May 2026 – From EuroPCR 2026

Focused on interventional therapies for pulmonary embolism, this session guides on establishing and sustaining Pulmonary Embolism Response Teams (PERT), refining patient selection for intervention, choosing appropriate technologies, and identifying intraprocedural markers indicating successful treatment outcomes.

All you need to know about interventional therapies for pulmonary embolism

Secondary mitral regurgitation: not all patients are the same

20 May 2026 – From EuroPCR 2026

Examining secondary mitral regurgitation, this session differentiates patient phenotypes and discusses the application of updated guideline recommendations. It offers practical guidance on selecting the appropriate device tailored to individual patient characteristics, supported by detailed case studies.

Managing life-threatening TAVI complications

19 May 2026 – From EuroPCR 2026

Manage life-threatening complications in TAVI procedures with a structured algorithm for identification and resolution. This session shares expert tips for handling specific severe complications and reviews best practices aimed at complication avoidance to enhance patient safety and procedural success.

All you need to know - Intracoronary imaging for vulnerable plaque

22 May 2026 – From EuroPCR 2026

This session provides a comprehensive overview of vulnerable plaque pathophysiology and the role of intracoronary imaging in its identification. It assesses treatment options, including the potential role of preventative PCI and intensive medical therapy, to guide clinical decision-making in managing plaque vulnerability.

How should I treat a patient with a calcified mitral anatomy?

19 May 2026 – From EuroPCR 2026

This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.

How to snare a TAVI when crossing is too complex

30 Jan 2025

Crossing the aortic valve can pose significant challenges, particularly in cases involving a horizontal aorta, bulky asymmetric calcifications, or prior prosthesis implantation in valve-in-valve procedures. While some TAVI devices feature deflectable delivery systems to enhance coaxiality, current self-expanding valves lack this capability. When standard techniques like...